Earnings Routine −

Charlotte's Web First Quarter 2026 Financial Results

Debt Relief Looms Over Revenue Decline as Liquidity Crunch Precedes Shareholder Vote

By The Northwire Desk — AI Analysis May 13, 2026 · 07:08 CWEB · 0.65 CHARLOTTE'S WEB HOLDINGS, INC.

Executive Summary

Q1 2026 Financial Results: Reported a net loss of $13.1 million, primarily driven by an $8.9 million non-cash fair value adjustment on convertible debentures. Revenue declined to $11.2 million from $12.3 million in Q1 2025.
Cash Position: Cash and cash equivalents dropped significantly to $5.2 million from $19.4 million a year prior, indicating high burn rates despite cost-cutting measures.
BAT Transaction Update: Confirms the proposed transaction with BT DE Investments Inc. (BAT) remains pending TSX and shareholder approval at the AGM/Special Meeting on May 28, 2026. The deal involves converting ~$54 million in debt plus accrued interest into equity and a $10 million private placement.
Operational Updates: CMS Substance Access Beneficiary Engagement Incentive (BEI) program activated April 1, 2026. Manufacturing internalization of gummies is substantially complete. Company qualified for OTCQX Best Market trading in late April.
Management Commentary: CEO Bill Morachnick states the company exited Q1 with elements to position for growth, citing an enhanced capital structure on the horizon. CFO Erika Lind notes revenue reduction improves product quality and channel mix but reduces near-term revenue.

Material Impact

Debt Conversion Impact: The proposed BAT transaction is material for solvency, eliminating ~$54 million in debt liability and $3 million in annual interest costs. However, this was previously announced as "Material - Positive" on March 30/31, 2026. This Q1 update confirms the financial state leading up to the vote but does not introduce new strategic value beyond the initial announcement.
Operational Miss: Revenue decline ($11.2M vs $12.3M) and cash burn ($5.2M remaining) are negative surprises relative to the "growth" narrative pushed in March. The company is burning cash while waiting for shareholder approval, creating execution risk before the capital injection closes.
Accounting Noise: The large net loss is largely non-cash (fair value adjustment), masking operational performance which shows Adjusted EBITDA of ($1.7 million). This indicates the core business remains unprofitable despite cost cuts.
Market Reaction: The stock has already corrected significantly from its February peak ($1.29) to current levels (~$0.65), suggesting the market is pricing in the revenue miss and liquidity risk prior to the May 28 vote.
Overall Materiality: While the debt conversion is critical, it is not new information. The operational deterioration (revenue down, cash low) creates a negative sentiment around the execution of the deal before closing.

CWEB · Price

Company Overview

Company: Charlotte's Web Holdings, Inc. is a hemp-derived CBD product manufacturer and distributor with a focus on wellness products including oils, gummies, and topicals.
Flagship Project: The company operates the DeFloria collaboration (with Ajna BioSciences and BAT) developing AJA001 for autism spectrum disorder irritability. This is their most advanced clinical asset (Phase 2 pending).
Business Model: Transitioning from pure consumer CBD to a medical channel model via Medicare/Medicaid pilot programs (CMMI BEI).
Manufacturing: Recently internalized gummy production at Louisville, CO facility to improve margins and control quality.

More from CHARLOTTE'S WEB HOLDINGS, INC.